The Toronto-based company is on a mission to become a leader in the consumer packaged goods (CPG) cannabidiol (CBD) market, with a focus on Europe and South America.
EuroLife’s COO Steve Loutskou told investors on Thursday that the company is exploring further opportunities to expand its business globally.
READ: EuroLife Brands brings on former Canopy Growth executive Alan Cooke to propel global expansion
"With continued forward progression in our activities since our rebrand to EuroLife Brands we have been aggressive in taking advantage of our deep connections in various CPG Brand industries suitable for CBD infusion," Loutskou said.
"We continue to drive company success across Europe and South America with potential investment and brand partners while vetting out strategic opportunities to expand business and increase shareholder value."
Earlier this year, the company rebranded to better reflect its business model, changing its name from Cannvas MedTech to EuroLife and adopting the ‘EURO’ ticker symbol on the Canadian Securities Exchange.
In the subsequent months, EuroLife obtained the exclusive rights to the True Focus brand, which develops a product that lessens the effects of THC overconsumption.
It also set up its South American headquarters in Medellin, Colombia.
EuroLife is also making investments into hemp and CBD for pets as well as CBD-based culinary experiences. The company also launched its first international cannabis education platform for the booming German market, Cannvas.de.
EuroLife said it expects to announce new partnerships in the coming months as its management team meets with some of the largest cultivators in the EU, as well as CBD extraction companies and other entrepreneurs in the CBD space.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas